Table 1 Her-2 status and estrogen and progesterone receptor expression in female breast carcinoma patients in Jordan
| Â | Her-2 weak positive | Her-2 strong positive | Her-2 negative | ER positive | ER negative | PR positive | PR negative |
|---|---|---|---|---|---|---|---|
Mean age (years)a | 43.7 | 42.3 | 53.2 | 52.40 | 43.68 | 50.74 | 45.71 |
No. of patients below 50 years of age | 15 | 17 | 18 | 21 | 29 | 24 | 26 |
No. of patients 50 years of age or older | 5 | 5 | 28 | 26 | 12 | 22 | 16 |
Mean size (cm)b | 4.9 | 4.72 | 4.02 | 3.57 | 5.3 | 4.06 | 4.79 |
No. of T1(up to 2 cm) tumors | 4 | 4 | 7 | 9 | 6 | 8 | 7 |
No. of T2 (more than 2 and up to 5 cm) tumors | 11 | 11 | 29 | 29 | 22 | 29 | 22 |
No. of T3 (more than 5 cm) tumors | 6 | 7 | 7 | 6 | 14 | 7 | 13 |
No lymph node metastasesc | 1 | 3 | 3 | 2 | 5 | 3 | 4 |
1–3 lymph node metastases | 3 | 5 | 8 | 7 | 9 | 10 | 6 |
More than 3 lymph node metastases | 9 | 10 | 8 | 13 | 14 | 13 | 14 |